3,7,12-trihydroxycoprostanic acid has been researched along with 7 alpha-hydroxy-4-cholesten-3-one in 1 studies
| Studies (3,7,12-trihydroxycoprostanic acid) | Trials (3,7,12-trihydroxycoprostanic acid) | Recent Studies (post-2010) (3,7,12-trihydroxycoprostanic acid) | Studies (7 alpha-hydroxy-4-cholesten-3-one) | Trials (7 alpha-hydroxy-4-cholesten-3-one) | Recent Studies (post-2010) (7 alpha-hydroxy-4-cholesten-3-one) |
|---|---|---|---|---|---|
| 31 | 0 | 0 | 134 | 28 | 59 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Björkhem, I; Kase, BF; Pedersen, JI; Strandvik, B | 1 |
1 other study(ies) available for 3,7,12-trihydroxycoprostanic acid and 7 alpha-hydroxy-4-cholesten-3-one
| Article | Year |
|---|---|
In vivo and vitro studies on formation of bile acids in patients with Zellweger syndrome. Evidence that peroxisomes are of importance in the normal biosynthesis of both cholic and chenodeoxycholic acid.
Topics: Bile Acids and Salts; Chenodeoxycholic Acid; Cholestenones; Cholic Acid; Cholic Acids; Humans; Kinetics; Liver Diseases; Metabolic Clearance Rate; Microbodies; Subcellular Fractions; Syndrome | 1985 |